Pharmaceutical formulation of carboxamide HIV integrase inhibitors containing a release rate controlling composition

Details for Australian Patent Application No. 2005311652 (hide)

Owner Merck Sharp & Dohme Corp.

Inventors Ney, James R.; Pourkavoos, Nazaneen; Wu, Yunhui; Cruanes, Maria T.; Palkar, Saurabh A.

Agent Spruson & Ferguson

Pub. Number AU-B-2005311652

PCT Pub. Number WO2006/060711

Priority 60/632,944 03.12.04 US

Filing date 2 December 2005

Wipo publication date 8 June 2006

Acceptance publication date 2 December 2010

International Classifications

A61K 31/513 (2006.01) - having oxo groups directly attached to the heterocyclic ring, e.g. cytosine

A61K 9/20 (2006.01) Medicinal preparations characterised by special physical form - Pills, lozenges or tablets

A61K 31/517 (2006.01) - ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine

A61P 31/18 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

Event Publications

7 June 2007 PCT application entered the National Phase

  PCT publication WO2006/060711 Priority application(s): WO2006/060711

28 January 2010 Alteration of Name

  The name of the applicant has been altered to Merck Sharp & Dohme Corp.

2 December 2010 Application Accepted

  Published as AU-B-2005311652

31 March 2011 Standard Patent Sealed

11 October 2012 Alteration of Name

  The name of the patentee has been altered to Merck Sharp & Dohme Corp.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005311655-Wood fiber plastic composites

2005311640-Methods of increasing seed yield